Medifast, Inc. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
Medifast, Inc. (MED) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $12.10 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-02-17
- Medifast, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $12.10M.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|
| 2025-12-31 | $12.10M 10-K · filed 2026-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COFFEE HOLDING CO INC (JVA) | United States | $0.023B | 4.10 |